Davy Global Fund Management Ltd
- SEC CIK
- 0001620943
- Latest filing
- Jul 31, 2026
BEAM holding history
Beam Therapeutics Inc. in every 13F filed by Davy Global Fund Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings
- Shares (Q2 2026)
- 455,954
- Value
- $15.6M
- % of portfolio
- 1.0%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 455,954 | $15.6M | 1.0% | −32,463−6.6% | Reduced | Holders |
| Q1 2026 | 488,417 | $11.6M | 0.9% | −45,146−8.5% | Reduced | Holders |
| Q4 2025 | 533,563 | $14.8M | 1.0% | +150,032+39.1% | Added | Holders |
| Q3 2025 | 383,531 | $9.31M | 0.6% | +188,243+96.4% | Added | Holders |
| Q2 2025 | 195,288 | $3.32M | 0.3% | +130,036+199.3% | Added | Holders |
| Q1 2025 | 65,252 | $1.27M | 0.1% | +33,054+102.7% | Added | Holders |
| Q4 2024 | 32,198 | $798.5K | 0.1% | +19,080+145.4% | Added | Holders |
| Q3 2024 | 13,118 | $321.4K | <0.1% | +3,815+41.0% | Added | Holders |
| Q2 2024 | 9,303 | $218.0K | <0.1% | +9,303 | New | Holders |